ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,230Medicare Part D Prescriptions Filled, Including Refills

Rank: 79 out of 1942

$499K Total Retail Price of All Prescriptions

Rank: 98 out of 1942

395 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
57% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Minnesota
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 395 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

10% of this provider’s 395 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

0% of this provider’s 7,594 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Minnesota
OMEPRAZOLE 439 345 1 4
SIMVASTATIN 384 307 2 1
LISINOPRIL 357 312 3 2
FUROSEMIDE 344 278 4 5
LEVOTHYROXINE SODIUM 278 246 5 3
METFORMIN HCL 271 219 6 10
CITALOPRAM HBR 256 191 7 15
METOPROLOL SUCCINATE 213 198 8 13
LISINOPRIL-HYDROCHLOROTHIAZIDE 208 177 9 22
GABAPENTIN 201 177 10 16
METOPROLOL TARTRATE 186 169 11 9
TRAMADOL HCL 184 122 12 19
HYDROCHLOROTHIAZIDE 181 151 13 8
WARFARIN SODIUM 180 144 14 11
AMLODIPINE BESYLATE 168 161 15 6
HYDROCODONE-ACETAMINOPHEN 148 93 S3 16 12
ATENOLOL 144 116 17 7
POTASSIUM CHLORIDE 141 97 18 17
PREDNISONE 124 92 19 27
RANITIDINE HCL 117 53 20 31
LOSARTAN POTASSIUM 103 86 21 18
SERTRALINE HCL 95 75 22 20
DIGOXIN 95 73 22 40
MIRTAZAPINE 95 82 22 38
TRAZODONE HCL 94 61 25 24
POLYETHYLENE GLYCOL 3350 89 72 26 28
ZOLPIDEM TARTRATE 88 66 27 25
DETROL LA 88 37 27 116
SPIRIVA 83 53 29 57
PRAVASTATIN SODIUM 83 72 29 23
DIOVAN 83 69 29 44
ISOSORBIDE MONONITRATE ER 79 79 32 42
ALLOPURINOL 73 57 33 26
CARBIDOPA-LEVODOPA 73 66 33 64
CLOPIDOGREL 72 71 35 55
QUETIAPINE FUMARATE 70 36 36 61
NEXIUM 62 21 37 58
DIVALPROEX SODIUM 58 24 38 91
CARVEDILOL 57 32 39 39
ATORVASTATIN CALCIUM 57 49 39 14
DILTIAZEM ER 57 57 39 121
VENTOLIN HFA 57 56 39 137
ALENDRONATE SODIUM 56 56 43 21
DONEPEZIL HCL 55 55 44 30
LYRICA 53 0 45 144
AMITRIPTYLINE HCL 51 13 R 46 65
LOVASTATIN 50 31 47 32
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 7, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.